Bingqi Tong
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Oncology top 10%
- Immunology
- Co-authors
- Thomas J. MaimoneDaniel K. NomuraMichael C. BassikRoberto ZoncuJames A. OlzmannPeter TangLeslie MagtanongKirill Bersuker
- Topics
- Protein Degradation and Inhibitors (6 papers)Ubiquitin and proteasome pathways (5 papers)Microbial Natural Products and Biosynthesis (3 papers)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Bingqi Tong
12 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 2.1k
- Pulmonary and Respiratory Medicine 2.0k
- Cancer Research 1.5k
- Oncology 393
- Immunology 168
Countries citing papers authored by Bingqi Tong
This map shows the geographic impact of Bingqi Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingqi Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingqi Tong more than expected).
Fields of papers citing papers by Bingqi Tong
This network shows the impact of papers produced by Bingqi Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingqi Tong. The network helps show where Bingqi Tong may publish in the future.
Co-authorship network of co-authors of Bingqi Tong
This figure shows the co-authorship network connecting the top 25 collaborators of Bingqi Tong. A scholar is included among the top collaborators of Bingqi Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingqi Tong. Bingqi Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 35 | |
| 5 | 6 | |
| 6 | 114 | |
| 7 | 100 | |
| 8 | 84 | |
| 9 | 1 | |
| 10 | The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosisbreakdown → | 2643 |
| 11 | 13 | |
| 12 | 41 | |
| 13 | 26 |
About Bingqi Tong
Bingqi Tong is a scholar working on Biotechnology, Hematology and Pharmacology, having authored 13 papers that have together received 3.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Microbial Natural Products and Biosynthesis (3 papers). The work is most often cited by research in Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Molecular Biology (2.1k citations). Bingqi Tong has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Thomas J. Maimone, Daniel K. Nomura, Michael C. Bassik, Roberto Zoncu, James A. Olzmann, Peter Tang, Leslie Magtanong, Kirill Bersuker, Joseph M. Hendricks and Melissa A. Roberts. Their work appears in journals such as Nature, Journal of the American Chemical Society and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.